Literature DB >> 22160618

Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells.

Kwan-Ki Hwang1, Xi Chen, Daniel M Kozink, Marietta Gustilo, Dawn J Marshall, John F Whitesides, Hua-Xin Liao, Rosa Catera, Charles C Chu, Xiao-Jie Yan, Micah A Luftig, Barton F Haynes, Nicholas Chiorazzi.   

Abstract

B-cell chronic lymphocytic leukemia (B-CLL) is characterized by the clonal expansion of CD5-expressing B lymphocytes that produce mAbs often reactive with microbial or autoantigens. Long-term culture of B-CLL clones would permit the collection and characterization of B-CLL mAbs to study antigen specificity and of B-CLL DNA to investigate molecular mechanisms promoting the disease. However, the derivation of long-term cell lines (eg, by EBV), has not been efficient. We have improved the efficiency of EBV B-CLL transformation of CpG oligonucleotide-stimulated cells by incubating patient peripheral blood mononuclear cells in the presence of an irradiated mouse macrophage cell line, J774A.1. Using this approach, peripheral blood mononuclear cells isolated from 13 of 21 B-CLL patients were transformed as documented by IGHV-D-J sequencing. Four clones grew and retained CD5 expression in culture for 2 to 4 months. However, despite documentation of EBV infection by expression of EBNA2 and LMP1, B-CLL cells died after removal of macrophage feeder cells. Nevertheless, using electrofusion technology, we generated 6 stable hetero-hybridoma cell lines from EBV-transformed B-CLL cells, and these hetero-hybridomas produced immunoglobulin. Thus, we have established enhanced methods of B-CLL culture that will enable broader interrogation of B-CLL cells at the genetic and protein levels.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160618      PMCID: PMC3286354          DOI: 10.1182/blood-2011-08-371203

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  EB virus-induced B lymphocyte cell lines producing specific antibody.

Authors:  M Steinitz; G Klein; S Koskimies; O Makel
Journal:  Nature       Date:  1977-09-29       Impact factor: 49.962

2.  Conditioned medium from macrophage cell lines supports the single-cell growth of hybridomas.

Authors:  D A Rathjen; C L Geczy
Journal:  Hybridoma       Date:  1986

3.  Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

Authors:  K M Kaye; K M Izumi; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

4.  Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro.

Authors:  P Panayiotidis; D Jones; K Ganeshaguru; L Foroni; A V Hoffbrand
Journal:  Br J Haematol       Date:  1996-01       Impact factor: 6.998

5.  Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies.

Authors:  B M Bröker; A Klajman; P Youinou; J Jouquan; C P Worman; J Murphy; L Mackenzie; R Quartey-Papafio; M Blaschek; P Collins
Journal:  J Autoimmun       Date:  1988-10       Impact factor: 7.094

6.  Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells.

Authors:  L Lagneaux; A Delforge; D Bron; C De Bruyn; P Stryckmans
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

7.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

8.  Generation and analysis of clonal IgM- and IgG-producing human B cell lines expressing an anti-DNA-associated idiotype.

Authors:  A J Manheimer-Lory; A Davidson; D Watkins; N R Hannigan; B A Diamond
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

9.  Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

Authors:  F Fais; F Ghiotto; S Hashimoto; B Sellars; A Valetto; S L Allen; P Schulman; V P Vinciguerra; K Rai; L Z Rassenti; T J Kipps; G Dighiero; H W Schroeder; M Ferrarini; N Chiorazzi
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

10.  Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.

Authors:  V Wendel-Hansen; J Sällström; P O De Campos-Lima; G Kjellström; A Sandlund; A Siegbahn; M Carlsson; K Nilsson; A Rosén
Journal:  Leukemia       Date:  1994-03       Impact factor: 11.528

View more
  5 in total

1.  In vitro induction of antibody secretion of primary B-cell chronic lymphocytic leukaemia cells.

Authors:  R Hoogeboom; R J A Reinten; J-J Schot; J E J Guikema; R J Bende; C J M van Noesel
Journal:  Leukemia       Date:  2014-09-10       Impact factor: 11.528

2.  A Selective Novel Peroxisome Proliferator-Activated Receptor (PPAR)-α Antagonist Induces Apoptosis and Inhibits Proliferation of CLL Cells In Vitro and In Vivo.

Authors:  Davorka Messmer; Kymmy Lorrain; Karin Stebbins; Yalda Bravo; Nicholas Stock; Geraldine Cabrera; Lucia Correa; Austin Chen; Jason Jacintho; Nicholas Chiorazzi; Xiao Jie Yan; David Spaner; Peppi Prasit; Daniel Lorrain
Journal:  Mol Med       Date:  2015-06-09       Impact factor: 6.354

3.  Hes1 Controls Proliferation and Apoptosis in Chronic Lymphoblastic Leukemia Cells by Modulating PTEN Expression.

Authors:  Qikai Zhang; Zongsi Zhu; Jiaqiang Guan; Yingying Hu; Wenjin Zhou; Wanchun Ye; Bijing Lin; Shanshan Weng; Yuemiao Chen; Cuiping Zheng
Journal:  Mol Biotechnol       Date:  2022-06-15       Impact factor: 2.860

4.  IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria.

Authors:  Kwan-Ki Hwang; Ashley M Trama; Daniel M Kozink; Xi Chen; Kevin Wiehe; Abby J Cooper; Shi-Mao Xia; Minyue Wang; Dawn J Marshall; John Whitesides; Munir Alam; Georgia D Tomaras; Steven L Allen; Kanti R Rai; Jane McKeating; Rosa Catera; Xiao-Jie Yan; Charles C Chu; Garnett Kelsoe; Hua-Xin Liao; Nicholas Chiorazzi; Barton F Haynes
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

5.  Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease.

Authors:  Erin Hertlein; Kyle A Beckwith; Gerard Lozanski; Timothy L Chen; William H Towns; Amy J Johnson; Amy Lehman; Amy S Ruppert; Brad Bolon; Leslie Andritsos; Arletta Lozanski; Laura Rassenti; Weiqiang Zhao; Tiina M Jarvinen; Leigha Senter; Carlo M Croce; David E Symer; Albert de la Chapelle; Nyla A Heerema; John C Byrd
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.